Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2025
2024
2023
2022
2021
2020
2019

2024.07.25

Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update

2024.07.12

Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September

2024.05.22

Adagene to Present at Investor Conferences in June

2024.03.29

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update

2024.03.07

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 6 - 10 of 80

Shareholder Tools

© 2025 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn